You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The subsidiary of Canon USA shut down as of Dec. 31 and terminated a distribution agreement with Dutch PCR company Molecular Biology Systems.
Canon Medical Systems established the Japanese joint venture — called ACTmed — with Taiwanese molecular diagnostics firm ACT Genomics.
The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips.
The deal covers Canon BioMedical's Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.
Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.
The method uses chitosan-coated magnetic beads and bead-based lysis to reduce the number of sample prep steps.
The companies have been working together since early 2015 on a diagnostic for the early detection of Lyme disease.
The firm has launched genotyping assays that rely on PCR followed by high-resolution melt analysis, as well as master mix companion chemistry.
The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.
Among Canon BioMedical's life science projects is a genetic testing platform based on ultra-fast serial PCR and high-resolution melt analysis.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.
